Postsurgical Outcomes of Mesial Temporal Lobe Epilepsy due to Hippocampal Sclerosis Associated with Calcified Neurocysticercosis

被引:1
|
作者
De la Cruz, Walter [1 ]
Sanchez-Boluarte, Sofia S. [1 ,2 ]
Chacon, Denisse E. [1 ]
Herrera, Manuel [3 ]
del Prado, Liza Nunez [1 ]
Vasquez, Carlos M. [4 ]
Delgado, Jose C. [1 ]
机构
[1] Inst Nacl Ciencias Neurol, Epilepsy Dept, Lima, Peru
[2] Univ Cesar Vallejo, Sch Med, Trujillo, Peru
[3] McMaster Univ, Dept Med, Hamilton, ON, Canada
[4] Inst Nacl Ciencias Neurol, Neurosurg Dept, Lima, Peru
来源
关键词
DRUG-RESISTANT EPILEPSY; INTRACTABLE EPILEPSY; SURGICAL-TREATMENT; ILAE COMMISSION; TASK-FORCE; LESIONS; EPILEPTOGENESIS; SEIZURES; SURGERY; SERUM;
D O I
10.4269/ajtmh.23-0506
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The aim of this study was to analyze postsurgical outcomes for individuals with mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) who underwent anterior temporal lobectomy, based on the presence of calcified neurocysticercosis (cNCC). A retrospective cross-sectional study was conducted on 89 patients with MTLE-HS who underwent anterior temporal lobectomy between January 2012 and December 2020 at a basic epilepsy surgery center located in Lima, Peru. We collected sociodemographic, clinical, and diagnostic information. The postsurgical results were analyzed using bivariate analysis according to the Engel classification. We included 89 individuals with a median age of 28 years (interquartile range [IQR]: 24-37), and more than half (55.1%) were male. Seventeen (19.1%) were diagnosed with cNCC. A greater number of patients with cNCC had lived in rural areas of Peru during their early life compared with those without cNCC (12 [70.6%] versus 26 [36.1%]; P = 0.010). Patients with cNCC exhibited a greater median frequency of focal to bilateral tonic-clonic seizures per month (1 [IQR: 0-2] versus 0 [0-0.5]; P = 0.009). Conversely, a lower proportion of patients with cNCC reported a history of an initial precipitating injury in comparison to the group without cNCC (4 [23.5%] versus 42 [58.3%]; P = 0.014). At the 1-year follow-up, most patients (82.4%) with cNCC were categorized as Engel IA. Similarly, at the 2-year follow-up, nine (75.0%) were classified as Engel IA. Our findings suggest that most patients diagnosed with cNCC exhibit favorable postsurgical outcomes, comparable to those without cNCC. Additionally, it can be postulated that cNCC may play a role as an initial precipitating injury.
引用
收藏
页码:700 / 705
页数:6
相关论文
共 50 条
  • [41] Immunogenetic predisposing factors for mesial temporal lobe epilepsy with hippocampal sclerosis
    Leal, Barbara
    Chaves, Joao
    Carvalho, Claudia
    Bettencourt, Andreia
    Brito, Claudia
    Boleixa, Daniela
    Freitas, Joel
    Bras, Sandra
    Lopes, Joao
    Ramalheira, Joao
    Costa, Paulo P.
    da Silva, Berta Martins
    da Silva, Antonio Martins
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2018, 128 (04) : 305 - 310
  • [42] Psychiatric Symptoms in Temporal Lobe Epilepsy with Left Mesial Hippocampal Sclerosis
    Jang, Hyun
    Kim, Sang Hoon
    Park, Sang Hag
    Choo, Il Han
    Kim, Seung Gon
    PSYCHIATRY INVESTIGATION, 2015, 12 (02) : 274 - 277
  • [43] Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis in Chorea-Acanthocytosis
    Mente, Karin
    Kim, Sun A.
    Grunseich, Christopher
    Hefti, Marco
    Crary, John
    Karp, Barbara
    Walker, Ruth
    NEUROLOGY, 2017, 88
  • [44] Mesial temporal lobe epilepsy with hippocampal sclerosis: Study of 42 children
    Cersosimo, Ricardo
    Flesler, Santiago
    Bartuluchi, Marcelo
    Maria Soprano, Ana
    Pomata, Hugo
    Caraballo, Roberto
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2011, 20 (02): : 131 - 137
  • [45] Personality features in patients of mesial temporal lobe epilepsy with hippocampal sclerosis
    Ozcanli, T.
    Ozmen, M.
    Ozkara, C.
    Erdogan, A.
    Baycora, S.
    Uzan, M.
    Maner, F.
    NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH, 2006, 13 (02) : 103 - 108
  • [46] Analysis of Reoperation in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis COMMENT
    Bingaman, William
    NEUROSURGERY, 2011, 68 (01) : 97 - 97
  • [47] LACOSAMIDE IN MESIAL TEMPORAL LOBE EPILEPSY (MTLE) WITH HIPPOCAMPAL SCLEROSIS (HS)
    Labate, A.
    Mumoli, L.
    Gambardella, A.
    Quattrone, A.
    Kraenzel, A. S.
    Li, W.
    Heinze, H. J.
    Schmitt, F.
    EPILEPSIA, 2014, 55 : 179 - 179
  • [48] Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis
    Palleria, Caterina
    Coppola, Antonietta
    Citraro, Rita
    Del Gaudio, Luigi
    Striano, Salvatore
    De Sarro, Giovambattista
    Russo, Emilio
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (15) : 2355 - 2371
  • [49] Temporal lobe epilepsy with mesial sclerosis
    Campanille, V
    Knorre, E
    Moschini, J
    Gori, H
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 82 - 82
  • [50] MESIAL TEMPORAL LOBE EPILEPSY - SYMPTOMATIC EPILEPSY WITH PARTIAL COMPLEX SEIZURES CAUSED BY HIPPOCAMPAL MESIAL SCLEROSIS
    Jurin, Maja
    Hecimovic, Hrvoje
    Sajko, Tomislav
    PAEDIATRIA CROATICA, 2011, 55 (02) : 147 - 150